Related Experiment Video
Updated: Nov 19, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated
Bosen You1,2,3, Yin Sun3, Jie Luo3
1Department of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Abstract:
While the androgen receptor (AR) may influence the progression of clear cell renal cell carcinoma (ccRCC), its role to impact vasculogenic mimicry (VM) to alter the ccRCC progression and metastasis remains obscure. Here, we demonstrated that elevated AR expression was positively correlated with tumor-originated vasculogenesis in ccRCC patients. Consistently, in vitro research revealed AR promoted VM formation in ccRCC cell lines via modulating lncRNA-TANAR/TWIST1 signals. Mechanism dissection showed that AR could increase lncRNA-TANAR (TANAR) expression through binding to the androgen response elements (AREs) located in its promoter region. Moreover, we found that TANAR could impede nonsense-mediated mRNA decay (NMD) of TWIST1 mRNA by direct interaction with TWIST1 5'UTR. A preclinical study using in vivo mouse model with orthotopic xenografts of ccRCC cells further confirmed the in vitro data. Together, these results illustrated that AR-mediated TANAR signals might play a crucial role in ccRCC VM formation and metastasis, and targeting this newly identified AR/TANAR/TWIST1 signaling may help in the development of a novel anti-angiogenesis therapy to better suppress the ccRCC progression.
Insights
Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) progression by enhancing vasculogenic mimicry (VM) through the lncRNA-TANAR/TWIST1 pathway. Targeting this AR/TANAR/TWIST1 signaling offers a potential new therapy for ccRCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The role of the androgen receptor (AR) in clear cell renal cell carcinoma (ccRCC) progression is known, but its specific impact on vasculogenic mimicry (VM) remains unclear.
- Vasculogenic mimicry (VM) is a process where tumor cells form vascular-like structures, contributing to tumor growth and metastasis in various cancers, including ccRCC.
Purpose of the Study:
- To investigate the influence of the androgen receptor (AR) on vasculogenic mimicry (VM) in clear cell renal cell carcinoma (ccRCC).
- To elucidate the molecular mechanisms by which AR affects VM and ccRCC progression.
- To explore the potential of targeting the AR/TANAR/TWIST1 signaling pathway for ccRCC therapy.
Main Methods:
- Correlation analysis between AR expression and tumor-originated vasculogenesis in ccRCC patients.
- In vitro studies using ccRCC cell lines to assess AR's effect on VM formation.
- Mechanistic studies involving AR binding to androgen response elements (AREs) and lncRNA-TANAR expression.
- Investigation of TANAR's interaction with TWIST1 mRNA and its effect on nonsense-mediated mRNA decay (NMD).
- In vivo preclinical studies using mouse models with orthotopic ccRCC xenografts.
Main Results:
- Elevated AR expression positively correlated with tumor-originated vasculogenesis in ccRCC patients.
- AR was found to promote VM formation in ccRCC cell lines by modulating lncRNA-TANAR/TWIST1 signaling.
- AR directly binds to AREs in the promoter region of lncRNA-TANAR, increasing its expression.
- lncRNA-TANAR interacts with TWIST1 mRNA, inhibiting its nonsense-mediated mRNA decay (NMD).
- In vivo studies confirmed the in vitro findings regarding the AR/TANAR/TWIST1 pathway's role in ccRCC.
Conclusions:
- The AR/TANAR/TWIST1 signaling pathway plays a critical role in ccRCC VM formation and metastasis.
- Targeting this newly identified AR-mediated pathway presents a potential novel anti-angiogenesis therapeutic strategy for ccRCC.
- Understanding this mechanism could lead to improved therapies to suppress ccRCC progression.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
